Stocks · NASDAQ · Healthcare · United States
RXRX — Recursion Pharmaceuticals
Recursion Pharmaceuticals (RXRX) is a healthcare stock listed on NASDAQ (United States). At the close of September 29, 2026 it traded at 4.03 (+8.92% on the day), +18.5% over one month, +9.8% over three months, -17.9% over twelve months. The InvestMuse composite score is -73 on a −100 to +100 scale, a strong bearish read that ranks #1195 of about 1,221 assets. The strongest of its nine dimensions are Momentum (+58) and Trend (+22); the weakest is Sector edge (-100). Its volatility regime from the hidden Markov model is Cool. 3 news articles in the last 30 days carried an average tone of -0.12 (on −1 to +1).
The facts
| Last close | 4.03 (September 29, 2026) |
|---|---|
| 1 day / 1 month / 3 months / 12 months | +8.92% / +18.5% / +9.8% / -17.9% |
| 52-week range | 2.84 – 6.79 |
| Composite score | -73 / 100 · strong bearish view · rank #1195 |
| Volatility regime (HMM) | Cool |
| Market cap | $2.0B |
The nine dimensions
Each dimension is scored from −100 to +100; the composite is their weighted blend. Composite of 9 dimensions; not a recommendation.
- Regime (hidden Markov model)-60
- Technical indicators-21
- Trend+22
- Support / resistance0
- Fundamentals-46
- Sector edge-100
- News sentiment-4
- Momentum+58
- Chart patterns and zones-60
How this read is made
Every night InvestMuse scores about 1,221 stocks, crypto assets, currencies, commodities and indices on nine dimensions: a hidden Markov model regime, technical indicators, trend, support and resistance from price clustering, fundamentals, the gap to sector peers, news sentiment, momentum, and chart patterns with demand/supply zones and Fibonacci levels. Members race each other with $100,000 of play money, against five fictional fund managers and the InvestMuse algorithm.
Data as of September 29, 2026. Observations from public market data — not investment advice, not a recommendation to buy or sell.